SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending due to significant progress with its ANKTIVA treatment, following a productive FDA meeting where no new clinical trials were requested for a bladder cancer indication, alongside recent Saudi FDA approval for lung cancer. The community is actively discussing the potential for a short and gamma squeeze, fueled by exceptionally high volume and conviction in the drug's "miracle" potential, believing this marks a turning point after previous regulatory hurdles.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following its announcement of a record date for a digital token initiative, drawing significant community discussion around its venture into crypto. This attention is amplified by escalating geopolitical rhetoric, including commentary on Greenland and new tariff threats, which is heavily influencing market sentiment and broader economic concerns. The stock continues to be a focal point for politically charged narratives, with both enthusiastic supporters and market participants expressing strong, polarized views.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to highly positive Phase 1 clinical trial results for its oral drug, soquelitinib, in treating moderate to severe atopic dermatitis, particularly in patients resistant to other therapies. The outstanding efficacy and safety profile from this early data are generating significant community excitement, with many anticipating blockbuster potential and a paradigm shift for inflammation and immunology, while some caution about the trial's small size and potential for a future stock offering.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending following its acquisition of Texas Critical Data Centers and a new partnership to co-develop a large-scale AI data center campus in West Texas. The community is actively discussing an anticipated hyperscaler tenant announcement, which many believe could significantly boost the stock. Despite some lingering concerns over past allegations, investors are keenly focused on the company's strategic advancements in the high-demand AI infrastructure sector.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing an unprecedented surge driven by escalating AI demand for memory chips, leading to a global supply shortage. This momentum is reinforced by significant capacity expansion initiatives, including a Taiwan fab acquisition and a New York megafab groundbreaking, alongside notable insider buying and analyst upgrades. While many celebrate its "monster" rally and market-leading strength, a segment of the community remains cautious, labeling it an "overextended" "bubble stock" due for a pullback.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following a significant non-exclusive licensing deal with Pfizer for its Matrix-M adjuvant, a move widely seen as powerful validation for the platform technology beyond its initial COVID application. The community is actively debating whether this partnership signals NVAX's evolution into a royalty-generating company and if high short interest will trigger a substantial upward move, despite some expressing frustration over the immediate market reaction amidst a broader downturn.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending as the community eagerly discusses its strategic expansion plans, including a new rare earth facility in France backed by government support, alongside advancements at its Stillwater magnet plant. These developments are viewed within the broader context of increasing geopolitical tensions and a global push for rare earth independence from traditional suppliers, though some express frustration over consistent price resistance and perceived manipulation compared to sector peers.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility amidst escalating geopolitical tensions, particularly surrounding tariffs and international relations, further compounded by ongoing uncertainty regarding the CLARITY Act. This environment has sharply divided the community, with many expressing concern about a potential "bear market" and questioning Bitcoin's "digital gold" narrative. Conversely, a substantial segment views current price action as a prime "buy the dip" opportunity, anticipating a significant rebound fueled by continued long-term accumulation.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The S&P 500 ETF (SPY) is experiencing heightened volatility and active discussion following new tariff threats against European allies and the Supreme Court's delayed ruling on existing tariffs. While many investors are seeing this as a 'buy the dip' opportunity, anticipating a swift market recovery, others are expressing deep concern over potential trade wars and broader implications for global trade relationships.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is gaining significant traction following key innovation awards and its confirmed partnership with Celestial AI, recently acquired by Marvell, igniting optimism for upcoming major customer announcements. The community is actively discussing strong market momentum and a potential gamma squeeze, highlighting the company's unique optical interposer technology as a critical enabler for AI and data center infrastructure.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.7% - Time to Sell?

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.7% - Here's What Happened...

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up - Should You Buy?

Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up - Time to Buy...

Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Given Average Rating of "Hold" by Analysts

Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE - Get Free Report) have earned an average recommendation of "Hold" from the five ratings firms that are currently covering the stock, Marketbeat...

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.6% - Time to Sell?

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 3.6% - What's Next...

Gyre Therapeutics (NASDAQ:GYRE) Shares Down 5.9% - Should You Sell?

Gyre Therapeutics (NASDAQ:GYRE) Trading Down 5.9% - What's Next...

Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 2.3% - Time to Buy?

Gyre Therapeutics (NASDAQ:GYRE) Trading 2.3% Higher - Still a Buy...

Gyre Therapeutics, Inc. (NASDAQ:GYRE) Receives Average Rating of "Hold" from Brokerages

Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE - Get Free Report) have received a consensus recommendation of "Hold" from the five ratings firms that are currently covering the stock, MarketBeat...

Gyre Therapeutics (NASDAQ:GYRE) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised shares of Gyre Therapeutics from a "hold" rating to a "buy" rating in a report on Saturday...

SBI Securities Co. Ltd. Purchases 108,670 Shares of Gyre Therapeutics, Inc. $GYRE

SBI Securities Co. Ltd. increased its holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE - Free Report) by 87.9% during the second quarter, according to its most recent disclosure with the SEC. The...

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.

GYRE
Gyre Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GYRE News

GYREGyre Therapeutics Inc